68 related articles for article (PubMed ID: 11532983)
1. Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability.
Jorquera R; Tanguay RM
Hum Mol Genet; 2001 Aug; 10(17):1741-52. PubMed ID: 11532983
[TBL] [Abstract][Full Text] [Related]
2. A specific activation of the mitogen-activated protein kinase kinase 1 (MEK1) is required for Golgi fragmentation during mitosis.
Colanzi A; Deerinck TJ; Ellisman MH; Malhotra V
J Cell Biol; 2000 Apr; 149(2):331-9. PubMed ID: 10769026
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic Signaling Alters Cell Shape and Mechanics to Facilitate Cell Division under Confinement.
Matthews HK; Ganguli S; Plak K; Taubenberger AV; Win Z; Williamson M; Piel M; Guck J; Baum B
Dev Cell; 2020 Mar; 52(5):563-573.e3. PubMed ID: 32032547
[TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein/extracellular signal-regulated kinase kinase 1act/tubulin interaction is an important determinant of mitotic stability in cultured HT1080 human fibrosarcoma cells.
Cao JN; Shafee N; Vickery L; Kaluz S; Ru N; Stanbridge EJ
Cancer Res; 2010 Jul; 70(14):6004-14. PubMed ID: 20570892
[TBL] [Abstract][Full Text] [Related]
5. Sustained ERK signaling promotes G2 cell cycle exit and primes cells for whole-genome duplication.
Guerrero Zuniga A; Aikin TJ; McKenney C; Lendner Y; Phung A; Hook PW; Meltzer A; Timp W; Regot S
Dev Cell; 2024 Apr; ():. PubMed ID: 38640927
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and Clinical Aspects of Hereditary Tyrosinemia Type 1.
Morrow G; Tanguay RM
Adv Exp Med Biol; 2017; 959():9-21. PubMed ID: 28755181
[TBL] [Abstract][Full Text] [Related]
7. Decoding hepatorenal tyrosinemia type 1: Unraveling the impact of early detection, NTBC, and the role of liver transplantation.
Kehar M; Sen Sarma M; Seetharaman J; Jimenez Rivera C; Chakraborty P
Can Liver J; 2024 Feb; 7(1):54-63. PubMed ID: 38505790
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with hepatorenal tyrosinemia from a single Egyptian center.
El-Karaksy H; Abdullatif HM; Ghobrial CM; Mogahed EA; Yasin NA; Talal N; Rashed M
PLoS One; 2022; 17(5):e0268017. PubMed ID: 35536841
[TBL] [Abstract][Full Text] [Related]
9. Hereditary Tyrosinemia Type 1 in Jordan: A Retrospective Study.
Megdadi NA; Almigdad AK; Alakil MO; Alqiam SM; Rababah SG; Dwiari MA
Int J Pediatr; 2021; 2021():3327277. PubMed ID: 34899923
[TBL] [Abstract][Full Text] [Related]
10. Hereditary tyrosinemia type Ⅰ: newborn screening, diagnosis and treatment.
Tang Y; Kong Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):514-523. PubMed ID: 34704422
[TBL] [Abstract][Full Text] [Related]
11. Fumarylacetoacetate hydrolase gene as a knockout target for hepatic chimerism and donor liver production.
Larson EL; Joo DJ; Nelson ED; Amiot BP; Aravalli RN; Nyberg SL
Stem Cell Reports; 2021 Nov; 16(11):2577-2588. PubMed ID: 34678209
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of dynamic thiol/disulfide homeostasis in hereditary tyrosinemia type 1 patients.
Aktuglu Zeybek AC; Kiykim E; Neselioglu S; Iscan HZ; Zubarioglu T; Cansever MS; Erel O
Pediatr Res; 2022 Aug; 92(2):474-479. PubMed ID: 34628487
[TBL] [Abstract][Full Text] [Related]
13. The Functional Hallmarks of Cancer Predisposition Genes.
Capellini A; Williams M; Onel K; Huang KL
Cancer Manag Res; 2021; 13():4351-4357. PubMed ID: 34103990
[TBL] [Abstract][Full Text] [Related]
14. Genetically blocking
Gu P; Yang Q; Chen B; Bie YN; Liu W; Tian Y; Luo H; Xu T; Liang C; Ye X; Liu Y; Tang X; Gu W
Mol Ther Methods Clin Dev; 2021 Jun; 21():530-547. PubMed ID: 33997102
[TBL] [Abstract][Full Text] [Related]
15. E3 Ubiquitin Ligase APC/C
Kaushal K; Woo SH; Tyagi A; Kim DH; Suresh B; Kim KS; Ramakrishna S
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218190
[TBL] [Abstract][Full Text] [Related]
16. Endogenous toxic metabolites and implications in cancer therapy.
Lee N; Spears ME; Carlisle AE; Kim D
Oncogene; 2020 Aug; 39(35):5709-5720. PubMed ID: 32709924
[TBL] [Abstract][Full Text] [Related]
17. Hedgehog signaling pathway regulates liver regeneration in the Fah
Xu X; Jiao X; Jiao Y; Wang M; Jiao C
Int J Clin Exp Pathol; 2017; 10(9):9837-9845. PubMed ID: 31966871
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1.
van Ginkel WG; Rodenburg IL; Harding CO; Hollak CEM; Heiner-Fokkema MR; van Spronsen FJ
Paediatr Drugs; 2019 Dec; 21(6):413-426. PubMed ID: 31667718
[TBL] [Abstract][Full Text] [Related]
19. Unusual first presentation of a metabolic disorder.
Strauss CE; Hann G
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30904888
[TBL] [Abstract][Full Text] [Related]
20. Fumarylacetoacetate hydrolase is involved in salt stress response in Arabidopsis.
Huang L; Hu C; Cai W; Zhu Q; Gao B; Zhang X; Ren C
Planta; 2018 Aug; 248(2):499-511. PubMed ID: 29785518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
